Fierce Healthcare September 10, 2019
A leaked summary of a proposal bill from House Speaker Nancy Pelosi to combat drug prices brought some good news for insurers and hospitals struggling with exorbitant drug costs, experts say.
The proposal, a draft of which was published by Bloomberg Business, would allow the Department of Health and Human Services each year to pick 250 brand-name drugs that lack at least two generic or biosimilar competitors. Medicare would have the power to negotiate with the drug maker for a rate for these products.
While the proposal hasn’t been officially released, it provides an outlook into how the Speaker’s office is handling the issue of drug prices this year.
Here is a look at how some sectors of the healthcare...